These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 29033194

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlations of CTLA-4 gene polymorphisms and hepatitis C chronic infection.
    Danilovic DL, Mendes-Correa MC, Lima EU, Zambrini H, K Barros R, Marui S.
    Liver Int; 2012 May; 32(5):803-8. PubMed ID: 22136395
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N, Ontiveros-Mercado H, Torres-Carrillo NM, Parra-Rojas I, Rangel-Villalobos H, Ramírez-Dueñas MG, Gutiérrez-Ureña SR, Valle Y, Muñoz-Valle JF.
    Cell Biochem Biophys; 2013 May; 67(3):1217-28. PubMed ID: 23703660
    [Abstract] [Full Text] [Related]

  • 5. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.
    Ali ESG, Bassyouni RH, Abdelaleem OO, Hassan EA, Gaber SN.
    Virus Res; 2022 Mar; 310():198684. PubMed ID: 35063794
    [Abstract] [Full Text] [Related]

  • 6. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E, Frydecka I, Bolanowski M, Tomkiewicz A, Jonkisz A, Karabon L, Partyka A, Nowak O, Szalinski M, Daroszewski J.
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [Abstract] [Full Text] [Related]

  • 7. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.
    Asian Pac J Cancer Prev; 2016 Jan; 17(8):3785-91. PubMed ID: 27644617
    [Abstract] [Full Text] [Related]

  • 8. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
    Al-Anazi MR, Matou-Nasri S, Abdo AA, Sanai FM, Khan MQ, Albenmousa A, Al-Ashgar HI, Khalaf NZ, Al-Ahdal MN, Al-Qahtani AA.
    BMC Infect Dis; 2014 Dec 31; 14():632. PubMed ID: 25551790
    [Abstract] [Full Text] [Related]

  • 9. [Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].
    Gao QJ, Liu DW, Zhang SY, Wu LH, Jia M.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep 31; 31(9):1041-5. PubMed ID: 21162873
    [Abstract] [Full Text] [Related]

  • 10. Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.
    Ksiaa Cheikhrouhou L, Lakhoua-Gorgi Y, Sfar I, Jendoubi-Ayed S, Aouadi H, Makhlouf M, Ayed K, Ben Abdallah T.
    World J Gastroenterol; 2015 Sep 21; 21(35):10150-8. PubMed ID: 26401079
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B.
    Mohammad Alizadeh AH, Hajilooi M, Ranjbar M, Fallahian F, Mousavi SM.
    World J Gastroenterol; 2006 Jan 28; 12(4):630-5. PubMed ID: 16489681
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.
    da Silva NM, Germano FN, Vidales-Braz BM, Carmo Zanella Rd, dos Santos DM, Lobato R, de Martinez AM.
    Cytokine; 2015 Jun 28; 73(2):253-7. PubMed ID: 25797191
    [Abstract] [Full Text] [Related]

  • 13. Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.
    Khorshied MM, Gouda HM, Khorshid OM.
    Leuk Lymphoma; 2014 May 28; 55(5):1061-6. PubMed ID: 23829277
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
    Naga M, Amin M, Algendy D, Elbadry A, Fawzi M, Foda A, Esmat S, Sabry D, Rashed L, Gabal S, Kamal M.
    World J Gastroenterol; 2015 Oct 21; 21(39):11141-51. PubMed ID: 26494968
    [Abstract] [Full Text] [Related]

  • 16. The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
    Al-Ghabban MJS, Al-Bayati NY, Al-Mayah QS, Al-Matubsi HY.
    Microb Pathog; 2021 Sep 21; 158():105073. PubMed ID: 34182077
    [Abstract] [Full Text] [Related]

  • 17. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
    Yu F, Miao J.
    Tumour Biol; 2013 Dec 21; 34(6):3371-5. PubMed ID: 23900675
    [Abstract] [Full Text] [Related]

  • 18. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.
    Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, Qadri I.
    J Infect Dev Ctries; 2011 Jul 04; 5(6):473-9. PubMed ID: 21727647
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W.
    DNA Cell Biol; 2011 Dec 04; 30(12):1051-5. PubMed ID: 21612409
    [Abstract] [Full Text] [Related]

  • 20. Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.
    Yee LJ, Perez KA, Tang J, van Leeuwen DJ, Kaslow RA.
    J Infect Dis; 2003 Apr 15; 187(8):1264-71. PubMed ID: 12696006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.